US Drug Recall Register

Is Chloride recalled?

Yes — there is an active recall. 326 ongoing FDA recalls mention Chloride (1,994 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chloride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

fentaNYL 2500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1093-37 D-0553-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1225-37 D-0552-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1104-36 D-0550-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1269-37 D-0549-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1259-75 D-0548-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1105-37 D-0547-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1160-37 D-0546-2020
Class III · Low risk Terminated

Amiodarone Hydrochloride Injection

Reason Crystallization: Presence of visible particulate matter.

AuroMedics Pharma LLC NDC 55150-182-18 D-0522-2020
Class III · Low risk Terminated

Amiodarone Hydrochloride Injection

Reason Crystallization: Presence of visible particulate matter.

AuroMedics Pharma LLC NDC 55150-181-09 D-0521-2020
Class III · Low risk Terminated

Amiodarone Hydrochloride Injection

Reason Crystallization: Presence of visible particulate matter.

AuroMedics Pharma LLC NDC 55150-180-03 D-0520-2020
Class II · Moderate risk Terminated

Valganciclovir Hydrochloride for Oral Solution

Reason Presence of foreign substance: Brown/black particles found during stability testing.

Teva Pharmaceuticals USA, Inc. NDC 0591-2579-20 D-0518-2020
Class II · Moderate risk Terminated

LETS GEL KIT Convenience Pack

Reason Microbial contamination of non-sterile product.

Fagron, Inc D-0533-2020
Class I · High risk Terminated

0.9% Sodium Chloride Injection

Reason Presence of Particulate Matter.

ICU Medical Inc NDC 0409-7983-25 D-0350-2020
Class III · Low risk Terminated

PF-Succinylcholine Chloride Injection

Reason Incorrect labeling: Incorrect or missing lot and/or exp date

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-919-10 D-0154-2020
Class II · Moderate risk Terminated

PF-Fentanyl Citrate

Reason GMP Deviations: potential glass contamination

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class III · Low risk Terminated

Motion Sickness Strips

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 69842-288-01 D-0325-2020
Class III · Low risk Terminated

Wal-Dram 2

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 0363-1407-01 D-0324-2020
Class III · Low risk Terminated

Motion Sickness

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 59779-534-01 D-0323-2020
Class III · Low risk Terminated

Zentrip

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 49873-803-01 D-0322-2020